Getting to the Heart of Chemotherapeutic Cardiotoxicity

On any given Tuesday, you will find Brian C. Jensen, MD, cardiologist and physician-scientist, tending to patients in his cardio-oncology clinic. His schedule is packed to the brim with cancer patients. But not patients with heart cancer. The largest number of patients he sees are cancer patients who have developed, or are at risk of developing, heart damage in response to their chemotherapy regimens.

Generous Philanthropic Gift Establishes New Cardio-Oncology Fellowship Program

A generous philanthropic gift has made it possible to establish a new Cardio-Oncology Fellowship Program at MedStar Washington Hospital Center. The J.D. Murphy Jr. Cardio-Oncology Fellowship program will be funded with a $500,000 gift from philanthropist Genevieve Murphy. The post-graduate training program is one of only a handful nationwide designed to train the next generation of cardio-oncology leaders.

Common drug may protect hearts from damage caused by breast cancer chemotherapy

New research from UHN’s Peter Munk Cardiac Centre (PMCC) shows statins, commonly prescribed to lower cholesterol and reduce the risk of heart disease and stroke, may also protect the heart from damaging side-effects of early breast cancer treatment.

Read-Across of Chemical Hepatotoxicants; Exposure-Based Cholinergic Synaptic Functional Deficits; and More Featured in April 2020 Toxicological Sciences

The April 2020 issue of the Society of Toxicology’s official journal, Toxicological Sciences, features leading research in toxicology, including several manuscripts covering emerging technologies, methods, and models.